Twist Bioscience Corp (TWST) released Loss for its second quarter of -$44.021 million
The company's bottom line totaled -$44.021 million, or -$0.71 per share. This compares with -$39.328 million, or -$0.66 per share, last year.
The company's revenue for the period rose 19.3% to $110.715 million from $92.793 million last year.
Twist Bioscience Corp earnings at a glance (GAAP) :
-Earnings: -$44.021 Mln. vs. -$39.328 Mln. last year.-EPS: -$0.71 vs. -$0.66 last year.-Revenue: $110.715 Mln vs. $92.793 Mln last year.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.